-
Xellia Pharmaceuticals appoints Hanne Junggreen as Corporate Vice President of Global Quality18 Jan 2023
-
Xellia Pharmaceuticals appoints John Stewart as Senior Vice President of Global Product Supply18 Jan 2023
-
Xellia Pharmaceuticals Joins End Drug Shortages Alliance16 Dec 2022
-
Xellia Pharmaceuticals secures $430m financing to support long-term growth08 Dec 2022
-
Celebrating World Quality Week 202207 Nov 2022
-
Xellia in the news, Berlingske Media Life Science Edition27 Oct 2022
-
Xellia Pharmaceuticals Joins the Pharmaceutical Supply Chain Initiative to Promote focus on Responsible Supply...27 Sep 2022
-
Surviving Sepsis: Importance of Timely Antibiotic Administration – A whitepaper sponsored by Xellia Pharmaceut...13 Sep 2022
-
Celebrating Diversity Inclusion & Belonging15 Aug 2022
-
The Impact of Pre-mix Intravenous Medication in the Pharmacy - A study by Virginia Mason Institute (VMI) spons...25 Jul 2022
-
Xellia Pharmaceuticals USA, LLC, Receives Supplier Horizon Award from Premier Inc.27 Jun 2022
-
Xellia Pharmaceuticals Reports 2021 Business Update and 2022 Outlook25 Apr 2022
-
Xellia Pharmaceuticals Cleveland, Ohio manufacturing facility commercially operational for production of key a...17 Aug 2021
-
Xellia Pharmaceuticals globally certified as a Great Place to Work® following company-wide employee survey21 Jun 2021
-
Xellia Pharmaceuticals receives Industrial Research and Innovation (IRI) Grant to support the development of V...28 Apr 2021
-
Celebrating Earth Day 2021!22 Apr 2021
-
Xellia in the news, Berlingske Media Life Science Edition - Fighting the Slow Pandemic19 Apr 2021
-
Xellia has signed the UN Women’s Empowerment Principles15 Apr 2021
-
Xellia Pharmaceuticals appoints Preben Haaning to its Board of Directors22 Mar 2021
-
Xellia Pharmaceuticals appoints Patrick Brunner as Vice President North America Manufacturing Operations and n...08 Mar 2021
-
Xellia Pharmaceuticals announces a new three-year collaboration agreement with SOS Children’s Villages, Denmar...09 Feb 2021
-
Xellia Pharmaceuticals joins Medicines for Europe to support better access to critical medicines21 Jan 2021
-
SOS Talk: Carl-Åke Carlsson, CEO & President of Xellia Pharmaceuticals, and Marianne Norup-Nielsen, Senior Dir...01 Dec 2020
-
Xellia joins World Antimicrobial Awareness Week on 18-24 November 202018 Nov 2020
-
Xellia celebrates World Quality Day on November 12th 202012 Nov 2020
-
Xellia Pharmaceuticals demonstrates commitment to the fight against sepsis by providing support for Sepsis Awa...29 Sep 2020
-
Podcast: Molecule to Market featuring Carl-Åke Carlsson, CEO & President Xellia Pharmaceuticals08 Sep 2020
-
The release of Xellia’s global recruitment film: Our Culture, Our Values, Our Purpose – Being an Xellian | Glo...24 Aug 2020
-
Xellia's response to the COVID-19 outbreak02 Jul 2020
-
Xellia Pharmaceuticals Opens New Commercial Office in Dubai19 Jun 2020
-
Xellia Pharmaceuticals recruiting additional >100 employees to expand workforce at its Cleveland, Ohio manufac...12 May 2020
-
The release of Xellia’s corporate film: Our Journey, Building for the Future.21 Apr 2020
-
Xellia Pharmaceuticals Reports Strong Full Year Results for 2019 and Provides Key Business Updates01 Apr 2020
-
Xellia Pharmaceuticals' site, Cleveland, Ohio, passes FDA inspection of Injectable Drug Manufacturing Methods,...26 Mar 2020
-
Xellia's response to the COVID-19 outbreak19 Mar 2020
-
Xellia’s response to the COVID-19 outbreak12 Mar 2020
-
Xellia Pharmaceuticals appoints Peter Baker as Chief Commercial Officer, Xellia North America11 Sep 2019
-
Xellia Pharmaceuticals Divests Raleigh, North Carolina Production Facilities to Sagent Pharmaceuticals01 Mar 2019
-
Xellia Pharmaceuticals welcomes HRH Princess Benedikte of Denmark to its Copenhagen Site14 Jan 2019
-
Xellia Pharmaceuticals Appoints Barbara Purcell to its Board of Directors03 Jan 2019
-
Xellia Pharmaceuticals Opens North American Commercial Office in Chicago18 Sep 2018
-
LEUKOCARE and Xellia Pharmaceuticals partner to discover innovative formulations06 Sep 2018
-
Xellia Pharmaceuticals Appoints Matthew Anderson as Chief Financial Officer13 Jun 2018
-
Xellia Pharmaceuticals Appoints Craig Boyd as President, Xellia US as it Expands its Commercial Organization23 Apr 2018
-
Xellia Pharmaceuticals Reports on Strong 2017 Financial Results and Advances in the Development of its Novel P...21 Mar 2018
-
Xellia Pharmaceuticals Welcomes VIPs from across Ohio as it prepares for Full Scale Manufacturing and Continue...14 Nov 2017
-
Xellia Pharmaceuticals Expands its Global Specialty Anti-infective Product Manufacturing Capabilities with a U...11 Oct 2017
-
The Xellia SOS Children’s Villages’ Medical Center Report18 Sep 2017
-
Xellia Pharmaceuticals Completes Expansion of its Budapest Facilities, Strengthening its Global Anti-infective...08 Aug 2017
-
Publication in Acquisition International: A Manufacturing 'One-Stop-Shop'24 Apr 2017
-
Publication in Pharma Horizon: Five minutes at DCAT with Carl-Åke Carlsson30 Mar 2017
-
Publication in Life Science Leader: Why Xellia Revived a Shuttered Pharma23 Mar 2017
-
Publication in S&P Global Market Intelligence: Small companies play big role in search for superbug killers23 Mar 2017
-
Publication in the Danish magazine Optimering: Xellia's Focus on Energy Consumption10 Mar 2017
-
Xellia Pharmaceuticals’ Increased Revenue by 17% in 201607 Feb 2017
-
Xellia Pharmaceuticals Signs Davos Declaration on Combating Antimicrobial Resistance18 Jan 2017
-
Xellia Pharmaceuticals Commences Packaging and Distribution Operations at Cleveland Site after Successful FDA ...14 Nov 2016
-
Xellia Pharmaceuticals Expands Croatian Anti-Infective Product and Innovation Capabilities to Tackle Antimicro...27 Sep 2016
-
Xellia Pharmaceuticals Welcomes Dignitaries from Hungarian Ministry of Foreign Affairs and Trade and Hungarian...31 May 2016
-
Xellia Pharmaceuticals Expands Budapest Facilities to Strengthen Anti-infective Product Capabilities25 May 2016
-
Xellia Pharmaceuticals Full Year Results for the year ended 31 December 201529 Apr 2016
-
Xellia Pharmaceuticals Reaches Agreement with FDA on Modifications to Consent Decree for Newly-Acquired Clevel...25 Apr 2016
-
Xellia Pharmaceuticals Expands US Production with Acquisition of Manufacturing Plant from Hikma Pharmaceutical...25 Nov 2015
-
Xellia Pharmaceuticals Expands Raleigh, NC Site to Become New North American Headquarters13 Aug 2015
-
Xellia Pharmaceuticals Focuses on Innovation in Anti-infectives with Formation of Scientific Advisory Board17 Dec 2014
-
On European Antibiotic Awareness Day Xellia Pharmaceuticals Strengthens Commitment to Innovation in Anti-Infec...18 Nov 2014
-
Xellia Pharmaceuticals Welcomes HM the Queen of Denmark to Zagreb R&D Center of Excellence During State Visit ...23 Oct 2014
-
Xellia Pharmaceuticals Seeks New Talent as it Expands Manufacturing Facility in Raleigh, NC15 Sep 2014
-
Xellia Pharmaceuticals Appoints Mads Bodenhoff as New Chief Financial Officer and Vice President01 Sep 2014
-
Xellia Pharmaceuticals Expands into the US with Acquisition of Manufacturing Plant07 Jul 2014
-
Xellia Pharmaceuticals Expands Croatian Product and Innovation R&D Centre of Excellence with Investment of US$...15 May 2014
-
Xellia Pharmaceuticals Appoints New Chairman and Board Members11 Nov 2013
-
Novo AS acquires Xellia Pharmaceuticals21 May 2013
-
Xellia Enters 4 Year Collaboration to Develop New Antibiotics to Combat Multi-Drug Resistant Bacteria25 Feb 2013
-
Xellia Pharmaceuticals appoints Hanne Junggreen as Corporate Vice President of Global Quality18 Jan 2023
-
Xellia Pharmaceuticals appoints John Stewart as Senior Vice President of Global Product Supply18 Jan 2023
-
Xellia Pharmaceuticals Joins End Drug Shortages Alliance16 Dec 2022
-
Xellia Pharmaceuticals secures $430m financing to support long-term growth08 Dec 2022
-
Celebrating World Quality Week 202207 Nov 2022
-
Xellia in the news, Berlingske Media Life Science Edition27 Oct 2022
-
Xellia Pharmaceuticals Joins the Pharmaceutical Supply Chain Initiative to Promote focus on Responsible Supply Chains and Business Practices27 Sep 2022
-
Surviving Sepsis: Importance of Timely Antibiotic Administration – A whitepaper sponsored by Xellia Pharmaceuticals USA LLC13 Sep 2022
-
Celebrating Diversity Inclusion & Belonging15 Aug 2022
-
The Impact of Pre-mix Intravenous Medication in the Pharmacy - A study by Virginia Mason Institute (VMI) sponsored by Xellia Pharmaceuticals USA LLC25 Jul 2022
-
Xellia Pharmaceuticals USA, LLC, Receives Supplier Horizon Award from Premier Inc.27 Jun 2022
-
Xellia Pharmaceuticals Reports 2021 Business Update and 2022 Outlook25 Apr 2022
-
Xellia Pharmaceuticals Cleveland, Ohio manufacturing facility commercially operational for production of key anti-infective drug products for US hospitals and patients17 Aug 2021
-
Xellia Pharmaceuticals globally certified as a Great Place to Work® following company-wide employee survey21 Jun 2021
-
Xellia Pharmaceuticals receives Industrial Research and Innovation (IRI) Grant to support the development of Value-Added Medicines (VAM) in the antibiotics space28 Apr 2021
-
Celebrating Earth Day 2021!22 Apr 2021
-
Xellia in the news, Berlingske Media Life Science Edition - Fighting the Slow Pandemic19 Apr 2021
-
Xellia has signed the UN Women’s Empowerment Principles15 Apr 2021
-
Xellia Pharmaceuticals appoints Preben Haaning to its Board of Directors22 Mar 2021
-
Xellia Pharmaceuticals appoints Patrick Brunner as Vice President North America Manufacturing Operations and new site head at its Cleveland, Ohio facility08 Mar 2021
-
Xellia Pharmaceuticals announces a new three-year collaboration agreement with SOS Children’s Villages, Denmark09 Feb 2021
-
Xellia Pharmaceuticals joins Medicines for Europe to support better access to critical medicines21 Jan 2021
-
SOS Talk: Carl-Åke Carlsson, CEO & President of Xellia Pharmaceuticals, and Marianne Norup-Nielsen, Senior Director Global IT, interviewed on our collaboration with SOS Children’s Villages01 Dec 2020
-
Xellia joins World Antimicrobial Awareness Week on 18-24 November 202018 Nov 2020
-
Xellia celebrates World Quality Day on November 12th 202012 Nov 2020
-
Xellia Pharmaceuticals demonstrates commitment to the fight against sepsis by providing support for Sepsis Awareness Month29 Sep 2020
-
Podcast: Molecule to Market featuring Carl-Åke Carlsson, CEO & President Xellia Pharmaceuticals08 Sep 2020
-
The release of Xellia’s global recruitment film: Our Culture, Our Values, Our Purpose – Being an Xellian | Global | Xellia Pharmaceuticals24 Aug 2020
-
Xellia's response to the COVID-19 outbreak02 Jul 2020
-
Xellia Pharmaceuticals Opens New Commercial Office in Dubai19 Jun 2020
-
Xellia Pharmaceuticals recruiting additional >100 employees to expand workforce at its Cleveland, Ohio manufacturing site12 May 2020
-
The release of Xellia’s corporate film: Our Journey, Building for the Future.21 Apr 2020
-
Xellia Pharmaceuticals Reports Strong Full Year Results for 2019 and Provides Key Business Updates01 Apr 2020
-
Xellia Pharmaceuticals' site, Cleveland, Ohio, passes FDA inspection of Injectable Drug Manufacturing Methods, Facilities, Processes & Controls26 Mar 2020
-
Xellia's response to the COVID-19 outbreak19 Mar 2020
-
Xellia’s response to the COVID-19 outbreak12 Mar 2020
-
Xellia Pharmaceuticals appoints Peter Baker as Chief Commercial Officer, Xellia North America11 Sep 2019
-
Xellia Pharmaceuticals Divests Raleigh, North Carolina Production Facilities to Sagent Pharmaceuticals01 Mar 2019
-
Xellia Pharmaceuticals welcomes HRH Princess Benedikte of Denmark to its Copenhagen Site14 Jan 2019
-
Xellia Pharmaceuticals Appoints Barbara Purcell to its Board of Directors03 Jan 2019
-
Xellia Pharmaceuticals Opens North American Commercial Office in Chicago18 Sep 2018
-
LEUKOCARE and Xellia Pharmaceuticals partner to discover innovative formulations06 Sep 2018
-
Xellia Pharmaceuticals Appoints Matthew Anderson as Chief Financial Officer13 Jun 2018
-
Xellia Pharmaceuticals Appoints Craig Boyd as President, Xellia US as it Expands its Commercial Organization23 Apr 2018
-
Xellia Pharmaceuticals Reports on Strong 2017 Financial Results and Advances in the Development of its Novel Premixed Vancomycin Ready-to-Use (RTU) Bag21 Mar 2018
-
Xellia Pharmaceuticals Welcomes VIPs from across Ohio as it prepares for Full Scale Manufacturing and Continues to Hire New Talent14 Nov 2017
-
Xellia Pharmaceuticals Expands its Global Specialty Anti-infective Product Manufacturing Capabilities with a US$25m Investment in its Copenhagen Site11 Oct 2017
-
The Xellia SOS Children’s Villages’ Medical Center Report18 Sep 2017
-
Xellia Pharmaceuticals Completes Expansion of its Budapest Facilities, Strengthening its Global Anti-infective Product Capabilities08 Aug 2017
-
Publication in Acquisition International: A Manufacturing 'One-Stop-Shop'24 Apr 2017
-
Publication in Pharma Horizon: Five minutes at DCAT with Carl-Åke Carlsson30 Mar 2017
-
Publication in Life Science Leader: Why Xellia Revived a Shuttered Pharma23 Mar 2017
-
Publication in S&P Global Market Intelligence: Small companies play big role in search for superbug killers23 Mar 2017
-
Publication in the Danish magazine Optimering: Xellia's Focus on Energy Consumption10 Mar 2017
-
Xellia Pharmaceuticals’ Increased Revenue by 17% in 201607 Feb 2017
-
Xellia Pharmaceuticals Signs Davos Declaration on Combating Antimicrobial Resistance18 Jan 2017
-
Xellia Pharmaceuticals Commences Packaging and Distribution Operations at Cleveland Site after Successful FDA Inspection14 Nov 2016
-
Xellia Pharmaceuticals Expands Croatian Anti-Infective Product and Innovation Capabilities to Tackle Antimicrobial Resistance Crisis27 Sep 2016
-
Xellia Pharmaceuticals Welcomes Dignitaries from Hungarian Ministry of Foreign Affairs and Trade and Hungarian Embassy to Copenhagen Headquarters31 May 2016
-
Xellia Pharmaceuticals Expands Budapest Facilities to Strengthen Anti-infective Product Capabilities25 May 2016
-
Xellia Pharmaceuticals Full Year Results for the year ended 31 December 201529 Apr 2016
-
Xellia Pharmaceuticals Reaches Agreement with FDA on Modifications to Consent Decree for Newly-Acquired Cleveland Site25 Apr 2016
-
Xellia Pharmaceuticals Expands US Production with Acquisition of Manufacturing Plant from Hikma Pharmaceuticals25 Nov 2015
-
Xellia Pharmaceuticals Expands Raleigh, NC Site to Become New North American Headquarters13 Aug 2015
-
Xellia Pharmaceuticals Focuses on Innovation in Anti-infectives with Formation of Scientific Advisory Board17 Dec 2014
-
On European Antibiotic Awareness Day Xellia Pharmaceuticals Strengthens Commitment to Innovation in Anti-Infectives with New API R&D Center of Excellence in Oslo18 Nov 2014
-
Xellia Pharmaceuticals Welcomes HM the Queen of Denmark to Zagreb R&D Center of Excellence During State Visit to Croatia23 Oct 2014
-
Xellia Pharmaceuticals Seeks New Talent as it Expands Manufacturing Facility in Raleigh, NC15 Sep 2014
-
Xellia Pharmaceuticals Appoints Mads Bodenhoff as New Chief Financial Officer and Vice President01 Sep 2014
-
Xellia Pharmaceuticals Expands into the US with Acquisition of Manufacturing Plant07 Jul 2014
-
Xellia Pharmaceuticals Expands Croatian Product and Innovation R&D Centre of Excellence with Investment of US$2.0 million15 May 2014
-
Xellia Pharmaceuticals Appoints New Chairman and Board Members11 Nov 2013
-
Novo AS acquires Xellia Pharmaceuticals21 May 2013
-
Xellia Enters 4 Year Collaboration to Develop New Antibiotics to Combat Multi-Drug Resistant Bacteria25 Feb 2013